Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma
Name:
35707756.pdf
Size:
421.4Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Kershaw, Lucy EForker, Laura-Jane
Roberts, Darren L
Sanderson, Benjamin
Shenjere, Patrick
Wylie, James P
Coyle, Catherine
Kochhar, Rohit
Manoharan, Prakash
Choudhury, Ananya
Affiliation
The University of Manchester, Manchester Academic Health Science Centre, The Christie NHSFT, ManchesterIssue Date
2021
Metadata
Show full item recordAbstract
Objective: Soft tissue sarcoma (STS) is a rare malignancy with a 5 year overall survival rate of 55%. Neoadjuvant radiotherapy is commonly used in preparation for surgery, but methods to assess early response are lacking despite pathological response at surgery being predictive of overall survival, local recurrence and distant metastasis. Multiparametric MR imaging (mpMRI) is used to assess response in a variety of tumours but lacks a robust, standardised method. The overall aim of this study was to develop a feasible imaging protocol to identify imaging biomarkers for further investigation. Methods: 15 patients with biopsy-confirmed STS suitable for pre-operative radiotherapy and radical surgery were imaged throughout treatment. The mpMRI protocol included anatomical, diffusion-weighted and dynamic contrast-enhanced imaging, giving estimates of apparent diffusion coefficient (ADC) and the area under the enhancement curve at 60 s (iAUC60). Histological analysis of resected tumours included detection of CD31, Ki67, hypoxia inducible factor and calculation of a hypoxia score. Results: There was a significant reduction in T1 at visit 2 and in ADC at visit 3. Significant associations were found between hypoxia and pre-treatment iAUC60, pre-treatment ADC and mid-treatment iAUC60. There was also statistically significant association between mid-treatment ADC and Ki67. Conclusion: This work showed that mpMRI throughout treatment is feasible in patients with STS having neoadjuvant radiotherapy. The relationships between imaging parameters, tissue biomarkers and clinical outcomes warrant further investigation.Citation
Kershaw L, Forker L, Roberts D, Sanderson B, Shenjere P, Wylie J, et al. Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma. Vol. 3, BJR|Open. British Institute of Radiology; 2021.Journal
BJR OpenDOI
10.1259/bjro.20200061PubMed ID
35707756Additional Links
https://dx.doi.org/10.1259/bjro.20200061Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1259/bjro.20200061
Scopus Count
Collections
Related articles
- Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers.
- Authors: Mahajan A, Engineer R, Chopra S, Mahanshetty U, Juvekar SL, Shrivastava SK, Desekar N, Thakur MH
- Issue date: 2016
- Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
- Authors: Lista F, Gimbernat H, Cáceres F, Rodríguez-Barbero JM, Castillo E, Angulo JC
- Issue date: 2014 Jun
- Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration.
- Authors: Brighi C, Verburg N, Koh ES, Walker A, Chen C, Pillay S, de Witt Hamer PC, Aly F, Holloway LC, Keall PJ, Waddington DEJ
- Issue date: 2022 Jul
- Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
- Authors: Tahmassebi A, Wengert GJ, Helbich TH, Bago-Horvath Z, Alaei S, Bartsch R, Dubsky P, Baltzer P, Clauser P, Kapetas P, Morris EA, Meyer-Baese A, Pinker K
- Issue date: 2019 Feb
- Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
- Authors: Saleh MM, Abdelrahman TM, Madney Y, Mohamed G, Shokry AM, Moustafa AF
- Issue date: 2020 Nov 1